Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$9.86 - $23.83 $820,352 - $1.98 Million
83,200 Added 2521.21%
86,500 $872,000
Q3 2022

Nov 14, 2022

BUY
$21.04 - $36.06 $69,432 - $118,998
3,300 New
3,300 $74,000
Q2 2022

Aug 15, 2022

SELL
$17.78 - $42.39 $10,668 - $25,434
-600 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$29.67 - $60.28 $26,703 - $54,252
-900 Reduced 60.0%
600 $23,000
Q4 2021

Feb 14, 2022

BUY
$47.84 - $64.34 $71,760 - $96,510
1,500 New
1,500 $88,000

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $90.2M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.